Futu News July 28 | the main index of Hong Kong stocks varies. The Hang Seng Index closed down 0.24% at 25027.16 points at midday; the national index rose 0.38%; and the Hang Seng Technology Index, which plummeted yesterday, fell slightly by 0.02%.

Plate aspectTechnology stocks closed mixed at midday. Tencent fell nearly 4%; Meituan fell slightly, after rising more than 11% at one point; NetEase, Inc rose nearly 6%, and JD.com, Baidu, Inc. and XIAOMI all rose more than 1%.

Sporting goods stocks rose, Li Ning Co. Ltd. rose by more than 10%, ANTA Sports Products by nearly 8%, Xtep International by nearly 5%, and China's trend by more than 3%.

Property management shares rose generally, with Country Garden Services Holdings up nearly 10%, Sunac Services up more than 5%, and Xincheng Hyatt Service up more than 3%. Earlier, HSBC research said that property management stocks had been oversold and the fundamentals were still strong.

Evergrande concept stocks rose, China Evergrande New Energy Vehicle rose 7.75%, Hengten.com rose more than 8%, Evergrande Property Services rose more than 2%.

Individual stocks$Sihuan Medicine (00460.HK) $More than 7%, and profits in the first half of the year are expected to increase by more than 300%.Sihuan Pharmaceutical announced that the Group expects to achieve a substantial increase of more than 80% and more than 300% respectively over the same period in 2020 in the first half of 2021. As of 09:20, it was up 8.89% to quote HK $2.45, with a turnover of 5.515 million.

$HUTCHMED (China) Limited (00013.HK) $Increase by more than 5%Start the phase II clinical trial with AstraZeneca PLC in the treatment of MET-amplified gastric cancer patients. Warressa is a potent and highly selective oral inhibitor of small molecular interstitial epithelial transforming factor (MET), a receptor tyrosine kinase, for the treatment of advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma amplified by MET. The first patient received medication on July 27, 2021. Macquarie said in a research report today that it gave HUTCHMED (China) Limited an "outperform" rating for the first time, with a target price of HK $83.31.

$Guangzhou Automobile Group (02238.HK) $It is down more than 4% and plans to more than double car sales by 2035.Guangzhou Automobile Group said in a statement on Tuesday that the company aims to produce and sell 5 million cars by 2035, with new energy vehicles accounting for 50 per cent of the total. By 2025, the group will produce and sell 3.5 million vehicles, with a market share of more than 12%, and new energy vehicles account for 20%, the statement said. Guangzhou Automobile Group's share of the new energy vehicle market in 2020 was 5.7%. The company plans to build Guangzhou Auto Zhaopin New Energy vehicle Industry Park into a globally competitive Guangdong-Hong Kong-Macau Greater Bay Area independent brand intelligent network and new energy vehicle industry cluster through a cumulative investment of 8.5-100 billion yuan.

$Wuxi Biologics (02269.HK) $It rose by more than 6%, and the commercial production of the German biological preparation factory was certified by the German health regulatory agency.A few days ago, Wuxi Biologics announced that the biological preparation factory (DP7) in Leverkusen, Germany, had been certified by the German health regulatory agency, which was Wuxi Biologics's first overseas GMP certification. Starting next week, DP7 is expected to start providing commercial production services for a predetermined product.

Nomura: to$Ping An Insurance (02318.HK) $The "buy" rating was lowered by 5 per cent to HK $106.04.Nomura released a research report that lowered its target price for Ping An Insurance's "buy" rating to HK $106.04 from HK $111.66, mainly due to a 100bp cut in its long-term RoEV to 14.5 per cent to reflect the weak momentum of its life insurance business and the latest market capitalization of its listed subsidiaries. Driven by the credit guarantee insurance business, the combined compensation rate of the property and accidental injury insurance business is expected to improve to 97.6 per cent in the first half of this year from 98.1 per cent in the first half of last year, the report said. However, due to the high base effect and the negative impact of auto insurance reform, the auto insurance business may still be under pressure to keep the forecast for the consolidated compensation rate for fiscal year 2021 unchanged.

Moto:$Meituan-W (03690.HK) $Short term「Selling pressure」Or continue, investors should start to absorb through weakness.According to a research report published by JPMorgan Chase & Co, the joint views recently published by the seven departments on the protection of riders on takeout platforms are basically consistent with the earlier regulatory development in Nanjing, believing that the relevant views will affect investor sentiment and trigger short-term selling pressure, and the investment atmosphere in the industry as a whole is also fragile. The bank believes that Meituan's profit target for the food delivery business in 2025 can still be easily met and has a potential upside, which is expected to support the valuation, while the selling pressure will continue in the short term, believing that investors can start to collect shares when the shares are weak, with a target price of HK $400. rating overweight. The bank believes that the only thing that has an immediate financial impact on the company is labor insurance, which estimates that the cost per rider and each order will increase by 0.05 yuan, or 0.03 yuan in terms of the total number of orders. however, the bank does not think it will bring risks to the earnings test of its food delivery business in 2021, but Maotong's community group buying business will face downside risks in the second half of the year.

Goldman Sachs Group: will$Byd Company Limited (01211.HK) $Include「Be sure to buy」List, the target price remains at HK $313.Goldman Sachs Group released a research report that put Byd Company Limited on the convinced buy list and maintained the target price of HK $313. Two things happened in the past two weeks: first, Tesla, Inc. mentioned in his second-quarter results that the automotive production mix of iron and nickel batteries would develop towards 2:1, and BYD announced that it would invest 10 billion yuan to build new battery capacity in Changchun, the report said. Coupled with the strength of China's electric vehicle industry in adding lithium iron phosphate (LFP) batteries, the bank believes it reflects an accelerating trend in global demand for iron batteries. In this context, the bank believes that BYD is attractive in two ways, leading the way in lithium-iron phosphate blade battery (blade-LFP) technology, and the company continues to increase lithium-iron phosphate battery capacity to position products for external sales.

Half-day turnover of Hong Kong stocks TOP 20